In addition, although there is yet to be the development of an anti-cancer therapy which targets the nuclear envelope proteins, drugs targeting nucleocytoplasmic export and import have shown promising outcomes in clinical and preclinical trials human and veterinary trials [91]. This evidence concerns the gene SUN2 and cancer.